Neurogenin-3 (NEUROG3) (NEUROG3)

Neurogenin-3 (NEUROG3) is a basic helix-loop-helix (bHLH) transcription factor that serves as the master regulator for the differentiation of endocrine progenitor cells in both the pancreas and the intestinal tract (UniProt P78337). During embryonic development, its transient expression is required to commit multipotent progenitor cells to an endocrine fate, leading to the formation of insulin-producing beta cells and other hormone-secreting cells (NCBI Gene 50674). While the protein itself is the functional unit, Neurog3 mRNA is frequently discussed in the context of regenerative medicine and gene therapy, where synthetic mRNA transcripts are delivered to non-endocrine tissues to induce reprogramming into functional beta-like cells for the treatment of Type 1 Diabetes (PubMed PMID: 18753626). Mutations in the NEUROG3 gene are clinically significant, causing rare conditions such as congenital malabsorptive diarrhea (enteric anendocrinosis) and neonatal diabetes due to the failure of endocrine cell development (PubMed PMID: 16415871). Currently, there are no approved small-molecule drugs targeting NEUROG3; however, it remains a high-priority target for cell-replacement therapies and in vivo reprogramming strategies using viral vectors or lipid nanoparticle-encapsulated mRNA.

Other names

NGN3bHLHa7Math4BAtonal homolog 4BProtein atonal homolog 4BClass A basic helix-loop-helix transcription factor 7

Induction of endocrine progenitor differentiation via transcriptional activation of downstream targets like NeuroD1 and Pax4 to drive lineage commitment (PubMed PMID: 18753626).